Bronte Capital Management PTY is an investment fund managing more than $1.28 trillion ran by Simon Maher. There are currently 26 companies in Mr. Maher’s portfolio. The largest investments include Alphabet Inc and Regeneron Pharmaceuticals, together worth $329 billion.
As of 31st July 2024, Bronte Capital Management PTY’s top holding is 1,003,523 shares of Alphabet Inc currently worth over $183 billion and making up 14.3% of the portfolio value.
Relative to the number of outstanding shares of Alphabet Inc, Bronte Capital Management PTY owns more than approximately 0.1% of the company.
In addition, the fund holds 139,454 shares of Regeneron Pharmaceuticals worth $147 billion, whose value grew 14.1% in the past six months.
The third-largest holding is Berkshire Hathaway worth $139 billion and the next is Interactive Brokers Inc worth $99.3 billion, with 809,799 shares owned.
Currently, Bronte Capital Management PTY's portfolio is worth at least $1.28 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Bronte Capital Management PTY office and employees reside in Bondi Junction, Australia. According to the last 13-F report filed with the SEC, Simon Maher serves as the Managing Director at Bronte Capital Management PTY.
In the most recent 13F filing, Bronte Capital Management PTY revealed that it had increased its stake in
Ishares Tr and bought 570,712 additional shares worth around .
On the other hand, there are companies that Bronte Capital Management PTY is getting rid of from its portfolio.
Bronte Capital Management PTY closed its position in CytomX Therapeutics Inc on 7th August 2024.
It sold the previously owned 906,157 shares for $1.98 billion.
Simon Maher also disclosed a decreased stake in Alphabet Inc by approximately 0.1%.
This leaves the value of the investment at $183 billion and 1,003,523 shares.
The two most similar investment funds to Bronte Capital Management PTY are Kanawha Capital Management and Segment Wealth Management. They manage $1.28 trillion and $1.28 trillion respectively.
Bronte Capital Management PTY’s portfolio is diversified across 8 sectors.
Currently, their heaviest sector is Technology — making up 22.5% of
the total portfolio value.
The fund focuses on investments in the United States as
53.8% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
42% of the total holdings value.
On the other hand, small-cap stocks make up only 3.8% of the portfolio.
The average market cap of the portfolio companies is close to $147 billion.
These positions were updated on August 7th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Alphabet Inc |
5.47%
1,003,523
|
$182,791,714,000 | 14.31% |
| Regeneron Pharmaceuticals, Inc. |
3.87%
139,454
|
$146,570,338,000 | 11.47% |
| Berkshire Hathaway Inc. |
5.59%
341,033
|
$138,732,224,000 | 10.86% |
| Interactive Brokers Group Inc |
3.87%
809,799
|
$99,281,357,000 | 7.77% |
| Ishares Tr |
94.14%
1,176,921
|
$133,867,149,000 | 10.48% |
| Amazon.com Inc. |
3.87%
383,277
|
$74,068,280,000 | 5.80% |
| Visa Inc-class A Shares |
3.87%
279,863
|
$73,455,642,000 | 5.75% |
| Pinterest Inc |
3.87%
1,350,583
|
$59,520,193,000 | 4.66% |
| Philip Morris International Inc |
12.88%
543,543
|
$55,077,212,000 | 4.31% |
| Hibbett Inc |
0.63%
605,382
|
$52,795,364,000 | 4.13% |
| Discover Finl Svcs |
31.66%
326,594
|
$42,721,761,000 | 3.34% |
| First Ctzns Bancshares Inc N |
6.77%
24,500
|
$41,248,445,000 | 3.23% |
| Match Group Inc. |
50.46%
1,130,236
|
$34,336,570,000 | 2.69% |
| Corteva Inc |
3.87%
593,303
|
$32,002,764,000 | 2.51% |
| Herbalife Nutrition Ltd |
3.87%
2,696,608
|
$28,017,757,000 | 2.19% |
| Graham Hldgs Co |
3.87%
21,537
|
$15,066,208,000 | 1.18% |
| Sotera Health Co |
3.87%
874,736
|
$10,383,116,000 | 0.81% |
| VanEck ETF Trust |
3.86%
361,908
|
$12,890,717,000 | 1.01% |
| Vertex Pharmaceuticals, Inc. |
3.87%
19,819
|
$9,289,562,000 | 0.73% |
| LiveRamp Holdings Inc |
21.44%
253,597
|
$7,846,291,000 | 0.61% |
| Bath Body Works Inc |
3.87%
179,925
|
$7,026,071,000 | 0.55% |
| BioNTech SE |
3.87%
77,292
|
$6,211,185,000 | 0.49% |
| Sociedad Quimica Y Minera De |
3.87%
139,215
|
$5,673,011,000 | 0.44% |
| Mondelez International Inc. |
3.87%
64,194
|
$4,200,855,000 | 0.33% |
| Riskified Ltd. |
3.87%
483,194
|
$3,087,610,000 | 0.24% |
| CytomX Therapeutics Inc |
Closed
906,157
|
$1,975,422,000 | |
| General Mls Inc |
50.97%
21,615
|
$1,367,365,000 | 0.11% |
| No transactions found | |||
| Showing first 500 out of 27 holdings | |||